Skip to main content
Premium Trial:

Request an Annual Quote

Anne Jones

Anne Jones has been appointed as CEO of Genomics Medicine Ireland. She joins the company from Danaher, where she was vice president and general manager for the Pall Corporations Lab, Food, and Beverage business. Prior to that, she was vice president of strategy and business development at Agilent Technologies. She also held various marketing and R&D roles at Amersham Biosciences in the UK and at GE Healthcare Life Sciences in the UK and the US. Jones holds a undergraduate degree in microbiology and molecular biology from the National University of Ireland and a PhD from Cancer Research UK.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.